1AD 3.85% 2.5¢ adalta limited

Biotech Ripper to Accumulate

  1. 2,092 Posts.
    lightbulb Created with Sketch. 103
    So path to human trials is relatively short.

    Four week toxicology study. Results due between now and Dec. These may come early

    Human Trials
    Phase 1 study to commence early Jan. Really very short time frame in biotech terms.

    Strong management team

    Really good chance to accumulate under 25 cents.

    Been stalking this for a couple of years.

    Giddy up!






 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $13.33M
Open High Low Value Volume
2.5¢ 2.7¢ 2.5¢ $26.44K 1.028M

Buyers (Bids)

No. Vol. Price($)
2 664357 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 54121 1
View Market Depth
Last trade - 11.14am 29/05/2024 (20 minute delay) ?
Last
2.7¢
  Change
-0.001 ( 3.85 %)
Open High Low Volume
2.5¢ 2.7¢ 2.5¢ 103667
Last updated 10.37am 29/05/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.